Best Alkylating Drug for leukemia, myelogenous, chronic, bcr-abl positive
The 2 Alkylating Drug options we list for leukemia, myelogenous, chronic, bcr-abl positive are all Busulfan— the same active ingredient in different brands or formulations, so they aren’t ranked against each other on effectiveness. Our score reflects each product’s FDA recall-safety record; the practical choice is brand vs generic, dose, and cost. Compare them with all treatments for leukemia, myelogenous, chronic, bcr-abl positive or the full Alkylating Drug class. Not medical advice — always consult a professional.
Quick answer: Of the 2 alkylating drug drugs we rate for leukemia, myelogenous, chronic, bcr-abl positive, none are yet flagged as generics in our price data, and most are injectable. Our ranking reflects each drug’s FDA recall-safety record — not clinical effectiveness for leukemia, myelogenous, chronic, bcr-abl positive; the right choice depends on your situation, so confirm it with your prescriber.
How alkylating drug work
Alkylating chemotherapy drugs attach chemical groups to a cell's DNA, forming cross-links that lock the two DNA strands together. This damage stops the cell from copying its DNA and dividing, which triggers it to die; because they are not limited to one phase of the cell cycle, they can act on cells whether or not they are actively dividing.
Other drug classes for leukemia, myelogenous, chronic, bcr-abl positive
These are all Busulfanin different brands or formulations, so we don’t rank them against each other — the list below is for comparing brand vs generic, dose, and typical cost, not for picking a “best” one on effectiveness.
All 2 alkylating drug products
busulfex
PrescriptionFDA-sourced
Busulfex (Busulfan) is an alkylating drug used to treat Polycythemia Vera, Bcr-Abl Positive Chronic Myelogenous Leukemia, Primary Myelofibrosis.
Price varies
myleran
Boxed warningPrescriptionFDA-sourced
Myleran (Busulfan) is an alkylating drug used to treat Polycythemia Vera, Bcr-Abl Positive Chronic Myelogenous Leukemia, Primary Myelofibrosis.
Price varies
Frequently asked
- What is the best alkylating drug for leukemia, myelogenous, chronic, bcr-abl positive?
- The Alkylating Drug options we list for leukemia, myelogenous, chronic, bcr-abl positive are all Busulfan — the same active ingredient in different brands or formulations — so there's no single "best" one on effectiveness; the practical choice is brand vs generic, dose, and cost. Always consult a professional.
- Which alkylating drug drugs treat leukemia, myelogenous, chronic, bcr-abl positive?
- pharmaranks lists 2 Alkylating Drug products used for leukemia, myelogenous, chronic, bcr-abl positive, per NIH RxClass drug-classification data — each independently rated and ranked above.
- How are these ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.